Ascites

Clinics in Liver Disease

Volumn 4, Issue 1, 2000, Pages 151-168

  Reynolds, Telfer B ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMILORIDE; AMMONIUM CHLORIDE; BUMETANIDE; CHLOROTHIAZIDE; CHLORTALIDONE; DIURETIC AGENT; ETACRYNIC ACID; FUROSEMIDE; HYDROCHLOROTHIAZIDE; LOOP DIURETIC AGENT; LYSINE; MERCURY DERIVATIVE; METOLAZONE; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM CHLORIDE; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; TORASEMIDE; TRIAMTERENE;

ASCITES; BACTERIAL PERITONITIS; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DRUG INDUCED DISEASE; HISTORY OF MEDICINE; HUMAN; HYDROTHORAX; KIDNEY TUBULE ABSORPTION; LIVER TRANSPLANTATION; PARACENTESIS; PATHOGENESIS; PERITONEUM VEIN SHUNT; PORTOSYSTEMIC ANASTOMOSIS; REVIEW; SODIUM RESTRICTION; SODIUM RETENTION;

EID: 0034424719     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70101-X     Document Type: Article

References (121)

1. Hyponatremia of cirrhosis: Role of vasopressin and decreased effective plasma volume
2. Is albumin infusion needed after large volume paracentesis in patients with refractory ascites?
3. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis
4. The mechanism of ascites formation in chronic liver disease
5. The hepatic hilar lymphatics of man
6. Small-bowel ulceration apparently associated with Thiazide and potassium therapy
7. Hemorrhagic shock induces bacterial translocation from the gut
8. La cure de dechloruration dans l'ascite cirrhotique
9. The causes of turbidity in milky ascitic fluids
10. The pathologic changes in the liver resulting from passive venous congestion experimentally produced
11. The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis
12. The treatment of refractory ascites by the LeVeen shunt: A multicenter controlled trial (57 patients)
13. Effect of indomethacin and prostaglandin A1 on renal function and plasma renin activity in alcoholic liver disease
14. Diagnostic value of ascitic fluid lactic dehydrogenase, protein and WBC levels
15. Amiloride: A potassium-sparing natriuretic agent
16. The causes of ascites: A study of five thousand cases
17. Pancreatic ascites
18. Surgical treatment of cirrhosis: Prognosis subsequent to omentopexy
19. Colloid osmotic pressure and hydrostatic pressure relationships in the formation of ascites in hepatic cirrhosis
20. Alcoholics and liver transplantation
21. Creation of an intrahepatic portosystemic shunt with a Gruntzig balloon catheter
22. Spontaneous peritonitis and bacteremia in Laennec's cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome
23. Surgical treatment of ascites
24. 9-α-fluorohydrocortisone-induced ascites in alcoholic liver disease
25. Case of ascites due to cirrhosis of liver cured by operation
26. The effect of rigid sodium restriction in patients with cirrhosis of the liver and ascites
27. Electrolyte studies on patients with cirrhosis of the liver
28. Relationship of portal hypertension to ascites in Laennec's cirrhosis
29. The physiological basis of diuretic synergism: Its role in treating diuretic resistance
30. Hydrothorax complicating ascites
31. Tetracycline-induced pleural symphysis for recurrent hydrothorax complicating cirrhosis
32. Electrolyte partition in patients with edema of various origins. Qualitative and quantitative definition of cations and anions in hepatic cirrhosis
33. The chemistry and cytology of serous fluids
34. Should portosystemic shunt be reconsidered in the treatment of intractable ascites in cirrhosis?
35. Recent progress in the physiology and biochemistry of the liver
36. Cirrhosis of the liver complicated by persistent right hydrothorax and ascites
37. Hepatic cirrhosis: Effects of sodium chloride administration and restriction and of abdominal paracentesis on electrolyte and water balance
38. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites
39. Comparison between paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study
40. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites
41. A trial natriuretic factor in cirrhosis with ascites: Plasma levels, cardiac release and splanchnic extraction
42. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind placebo-controlled trial
43. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis
44. The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt
45. Ascites in patients undergoing maintenance hemodialysis
46. Myxoedema and ascites
47. Combined staff clinic: Mechanisms of ascites formation
48. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease
49. Spontaneous bacterial peritonitis
50. The mechanism of ascites. A physiological appraisal
51. The effect of increased intra-abdominal pressure on hepatic hemodynamics in patients with chronic liver disease and portal hypertension
52. Action of new steroids in blocking effects of aldosterone and deoxycorticosterone on salt
53. The effect of large volume paracentesis on plasma volume - A cause of hypovolemia?
54. A study of the action of ammonium chloride and organic mercury compounds
55. Infection of ascitic fluid in patients with hepatic cirrhosis
56. Circulation times in the splanchnic and hepatic beds in a alcoholic liver disease
57. Orthotopic liver transplantation for alcoholic liver disease
58. The proper use of newer diuretics
59. Physiologic and clinical observations on furosemide and ethacrynic acid
60. Effect of chlorothiazide on electrolyte transport in man: Its use in the treatment of edema of congestive heart failure, nephrosis and cirrhosis
61. Transjugular intrahepatic portosystemic shunt: Comparison with paracentesis in patients with cirrhosis and refractory ascites: A randomized trial
62. Peritoneo-venous shunting for ascites
63. Sodium retention and ascites formation in dogs with experimental portal cirrhosis
64. Treatment of ascites by reinfusion of concentrated peritoneal fluid-review of 318 procedures in 210 patients
65. The relationship of plasma volume, portal hypertension, ascites, and renal sodium retention in cirrhosis: The overflow theory of ascites formation
66. Pathogenesis and treatment of hydrothorax complicating cirrhosis with ascites
67. Cirrhotic hydrothorax. Further evidence that an acquired diaphragmatic defect is at fault
68. Plasma volume in cirrhosis of the liver: Its relation to portal hypertension, ascites and renal failure
69. Pleural effusions: The diagnostic separation of transudates and exudates
70. Dynamics of ascites formation in rats with experimental cirrhosis
71. Alcohol use after liver transplantation in alcoholics: A clinical cohort follow-up study
72. Observations on the sodium retaining corticoid (aldosterone) in the urine of children and adults in relation to sodium balance and edema
73. Total adrenalectomy in hepatic cirrhosis with ascites
74. Nitric oxide as a mediator of hemodynamic abnormalities and sodium and water retention in cirrhosis
75. Usefulness of serum-ascites albumin difference in separating transudative from exudative ascites
76. Vascular lesions of portal cirrhosis
77. Fibroma of the ovary with ascites and hydrothorax with a report of seven cases
78. Hepatic hydrothorax
79. Should alcoholics compete for liver transplantation?
80. Relation of plasma proteins to ascites and edema in cirrhosis of the liver
81. Hyponatremia in hepatic cirrhosis following paracentesis
82. The transjugular intrahepatic portosystemic stentshunt procedure for refractory ascites
83. Effect of side-to-side portacaval shunt on intractable ascites, sodium excretion and aldosterone metabolism in man
84. The diagnostic significance of serous fluids in disease
85. Expandable intrahepatic portacaval shunt stents: Early experience in the dog
86. Treatment of ascites by continuous ultrafiltration and reinfusion of protein concentrate
87. Serum-ascites albumin concentration gradient: A physiological approach to the differential diagnosis of ascites
88. Large volume paracentesis in non-edematous patients with tense ascites: Its effect on intravascular volume
89. Rapid diuresis in patients with ascites from chronic liver disease: The importance of peripheral edema
90. Superiority of the serum-ascites albumin difference over ascites total protein concentration in separation of "transudative" and "exudative" ascites
91. Therapeutic paracentesis. Have we come full circle?
92. The transjugular intrahepatic portosystemic stent-shunt (TIPSS): Results of a pilot study
93. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: Results of a prospective controlled trial
94. Novasurol in the treatment of ascites in hepatic disease
95. Hepatic hydrothorax in the absence of clinical ascites: Diagnosis and management
96. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis
97. Management of adult patients with ascites caused by cirrhosis
98. Patients with deficient ascitic fluid opsonic activity are predisposed to spontaneous bacterial peritonitis
99. Spontaneous bacterial peritonitis: An explosion of information
100. Optimization of ascitic fluid culture technique
101. Short-course versus long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study of 100 patients
102. The utility of the serum-ascites albumin gradient in the differential diagnosis of ascites: Analysis of 901 paired specimens
103. Coagulopathy of peritoneovenous shunts: Studies on the pathogenic role of ascitic fluid collagen and value of antiplatelet therapy
104. Effect of therapeutic paracentesis on plasma volume and transvascular escape rate of albumin in patients with cirrhosis
105. High protein ascites in patients with uncomplicated hepatic cirrhosis
106. Experimental ascites. Studies of electrolyte balance in dogs with partial and complete occlusion of the portal vein and of the inferior vena cava above and below the liver
107. Peripheral arterial vasodilatation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis
108. Complications of diuretic therapy in hepatic cirrhosis
109. Cirrhotic pleural effusion in the absence of ascites
110. Trimethoprim-sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: A randomized study
111. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites
112. On the absorption of fluids from the connective tissue spaces
113. The influence of mechanical factors on lymph production
114. On absorption from and secretion into the serous cavities
115. Preliminary observations on the antidiuretic substance recovered from the urines of patients with cirrhosis of the liver
116. Recurrence of spontaneous bacterial peritonitis in cirrhosis: Frequency and predictive factors
117. Effect of hepatic venous pressure on liver function and ascites formation
118. Hemodynamic changes in patients developing effective hypovolemia after total paracentesis
119. Increased blood flow through the portal system in cirrhotic rats
120. The relationship between portal pressure and plasma albumin in the development of cirrhotic ascites